nodes	percent_of_prediction	percent_of_DWPC	metapath
Drospirenone—NR3C2—Prednisolone—chronic obstructive pulmonary disease	0.309	1	CbGbCtD
Drospirenone—Potassium Canrenoate—Prednisone—chronic obstructive pulmonary disease	0.0595	0.104	CrCrCtD
Drospirenone—Potassium Canrenoate—Prednisolone—chronic obstructive pulmonary disease	0.0581	0.101	CrCrCtD
Drospirenone—Medrysone—Prednisolone—chronic obstructive pulmonary disease	0.0491	0.0854	CrCrCtD
Drospirenone—Flurandrenolide—Prednisolone—chronic obstructive pulmonary disease	0.0456	0.0794	CrCrCtD
Drospirenone—Cortisone acetate—Prednisone—chronic obstructive pulmonary disease	0.0424	0.0737	CrCrCtD
Drospirenone—Cortisone acetate—Prednisolone—chronic obstructive pulmonary disease	0.0414	0.072	CrCrCtD
Drospirenone—Testolactone—Prednisone—chronic obstructive pulmonary disease	0.0411	0.0715	CrCrCtD
Drospirenone—Testolactone—Prednisolone—chronic obstructive pulmonary disease	0.0401	0.0698	CrCrCtD
Drospirenone—Progesterone—Prednisolone—chronic obstructive pulmonary disease	0.0359	0.0625	CrCrCtD
Drospirenone—Methyltestosterone—Prednisone—chronic obstructive pulmonary disease	0.0359	0.0624	CrCrCtD
Drospirenone—Methyltestosterone—Prednisolone—chronic obstructive pulmonary disease	0.035	0.061	CrCrCtD
Drospirenone—Testosterone—Prednisolone—chronic obstructive pulmonary disease	0.0312	0.0543	CrCrCtD
Drospirenone—Hydrocortisone—Prednisone—chronic obstructive pulmonary disease	0.03	0.0522	CrCrCtD
Drospirenone—Hydrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.0293	0.051	CrCrCtD
Drospirenone—BCHE—diaphragm—chronic obstructive pulmonary disease	0.0112	0.255	CbGeAlD
Drospirenone—Cerebral infarction—Arformoterol—chronic obstructive pulmonary disease	0.00425	0.0817	CcSEcCtD
Drospirenone—Cerebral infarction—Formoterol—chronic obstructive pulmonary disease	0.00425	0.0817	CcSEcCtD
Drospirenone—PTGS2—leg—chronic obstructive pulmonary disease	0.00398	0.0902	CbGeAlD
Drospirenone—PGR—respiratory system—chronic obstructive pulmonary disease	0.00198	0.0448	CbGeAlD
Drospirenone—NR3C2—connective tissue—chronic obstructive pulmonary disease	0.00187	0.0425	CbGeAlD
Drospirenone—NR3C2—ACE Inhibitor Pathway—ACE—chronic obstructive pulmonary disease	0.00176	0.0905	CbGpPWpGaD
Drospirenone—NR3C2—bronchus—chronic obstructive pulmonary disease	0.00175	0.0397	CbGeAlD
Drospirenone—PGR—connective tissue—chronic obstructive pulmonary disease	0.00174	0.0395	CbGeAlD
Drospirenone—NR3C2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00171	0.0388	CbGeAlD
Drospirenone—PGR—smooth muscle tissue—chronic obstructive pulmonary disease	0.00159	0.0361	CbGeAlD
Drospirenone—NR3C2—trachea—chronic obstructive pulmonary disease	0.00157	0.0356	CbGeAlD
Drospirenone—Depression—Roflumilast—chronic obstructive pulmonary disease	0.00152	0.0293	CcSEcCtD
Drospirenone—Breast pain—Salbutamol—chronic obstructive pulmonary disease	0.0015	0.0288	CcSEcCtD
Drospirenone—Embolism venous—Prednisolone—chronic obstructive pulmonary disease	0.00149	0.0286	CcSEcCtD
Drospirenone—AR—connective tissue—chronic obstructive pulmonary disease	0.00139	0.0314	CbGeAlD
Drospirenone—AR—bronchus—chronic obstructive pulmonary disease	0.0013	0.0294	CbGeAlD
Drospirenone—BCHE—respiratory system—chronic obstructive pulmonary disease	0.00128	0.0291	CbGeAlD
Drospirenone—AR—smooth muscle tissue—chronic obstructive pulmonary disease	0.00127	0.0288	CbGeAlD
Drospirenone—Mental disorder—Roflumilast—chronic obstructive pulmonary disease	0.0012	0.0231	CcSEcCtD
Drospirenone—AR—FOXA1 transcription factor network—SCGB1A1—chronic obstructive pulmonary disease	0.00119	0.0614	CbGpPWpGaD
Drospirenone—Embolism—Prednisolone—chronic obstructive pulmonary disease	0.00117	0.0225	CcSEcCtD
Drospirenone—NR3C2—lung—chronic obstructive pulmonary disease	0.00113	0.0256	CbGeAlD
Drospirenone—Embolism venous—Prednisone—chronic obstructive pulmonary disease	0.00108	0.0208	CcSEcCtD
Drospirenone—BCHE—bronchus—chronic obstructive pulmonary disease	0.00106	0.0239	CbGeAlD
Drospirenone—PGR—lung—chronic obstructive pulmonary disease	0.00105	0.0238	CbGeAlD
Drospirenone—BCHE—smooth muscle tissue—chronic obstructive pulmonary disease	0.00103	0.0234	CbGeAlD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00101	0.0194	CcSEcCtD
Drospirenone—PTGS2—respiratory system—chronic obstructive pulmonary disease	0.000988	0.0224	CbGeAlD
Drospirenone—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.000955	0.0184	CcSEcCtD
Drospirenone—BCHE—trachea—chronic obstructive pulmonary disease	0.000948	0.0215	CbGeAlD
Drospirenone—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.000946	0.0182	CcSEcCtD
Drospirenone—Affect lability—Salbutamol—chronic obstructive pulmonary disease	0.000935	0.018	CcSEcCtD
Drospirenone—Migraine—Salbutamol—chronic obstructive pulmonary disease	0.000935	0.018	CcSEcCtD
Drospirenone—PTGS2—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.000932	0.048	CbGpPWpGaD
Drospirenone—AR—FOXA1 transcription factor network—SFTPD—chronic obstructive pulmonary disease	0.000904	0.0466	CbGpPWpGaD
Drospirenone—Mood swings—Salbutamol—chronic obstructive pulmonary disease	0.0009	0.0173	CcSEcCtD
Drospirenone—PTGS2—connective tissue—chronic obstructive pulmonary disease	0.00087	0.0197	CbGeAlD
Drospirenone—Embolism—Prednisone—chronic obstructive pulmonary disease	0.000849	0.0163	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000841	0.0162	CcSEcCtD
Drospirenone—AR—lung—chronic obstructive pulmonary disease	0.000837	0.019	CbGeAlD
Drospirenone—NR3C2—ACE Inhibitor Pathway—NOS3—chronic obstructive pulmonary disease	0.000818	0.0421	CbGpPWpGaD
Drospirenone—PTGS2—bronchus—chronic obstructive pulmonary disease	0.000813	0.0184	CbGeAlD
Drospirenone—PTGS2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000796	0.018	CbGeAlD
Drospirenone—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.000782	0.015	CcSEcCtD
Drospirenone—Acute coronary syndrome—Formoterol—chronic obstructive pulmonary disease	0.000764	0.0147	CcSEcCtD
Drospirenone—Acute coronary syndrome—Arformoterol—chronic obstructive pulmonary disease	0.000764	0.0147	CcSEcCtD
Drospirenone—Myocardial infarction—Arformoterol—chronic obstructive pulmonary disease	0.00076	0.0146	CcSEcCtD
Drospirenone—Myocardial infarction—Formoterol—chronic obstructive pulmonary disease	0.00076	0.0146	CcSEcCtD
Drospirenone—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.000755	0.0145	CcSEcCtD
Drospirenone—PTGS2—trachea—chronic obstructive pulmonary disease	0.00073	0.0165	CbGeAlD
Drospirenone—BCHE—lung—chronic obstructive pulmonary disease	0.000681	0.0154	CbGeAlD
Drospirenone—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00066	0.0127	CcSEcCtD
Drospirenone—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.000657	0.0126	CcSEcCtD
Drospirenone—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.000644	0.0124	CcSEcCtD
Drospirenone—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000637	0.0122	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000635	0.0122	CcSEcCtD
Drospirenone—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.00061	0.0117	CcSEcCtD
Drospirenone—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.00061	0.0117	CcSEcCtD
Drospirenone—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000601	0.0115	CcSEcCtD
Drospirenone—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000597	0.0115	CcSEcCtD
Drospirenone—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000596	0.0115	CcSEcCtD
Drospirenone—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000595	0.0114	CcSEcCtD
Drospirenone—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000579	0.0111	CcSEcCtD
Drospirenone—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000576	0.0111	CcSEcCtD
Drospirenone—NR3C2—ACE Inhibitor Pathway—TGFB1—chronic obstructive pulmonary disease	0.000541	0.0279	CbGpPWpGaD
Drospirenone—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.000536	0.0103	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000529	0.0102	CcSEcCtD
Drospirenone—PTGS2—lung—chronic obstructive pulmonary disease	0.000525	0.0119	CbGeAlD
Drospirenone—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000516	0.00992	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000512	0.00984	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000512	0.00984	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000502	0.00964	CcSEcCtD
Drospirenone—AR—FOXA1 transcription factor network—SERPINA1—chronic obstructive pulmonary disease	0.000488	0.0251	CbGpPWpGaD
Drospirenone—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000485	0.00932	CcSEcCtD
Drospirenone—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000485	0.00932	CcSEcCtD
Drospirenone—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00048	0.00923	CcSEcCtD
Drospirenone—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00048	0.00923	CcSEcCtD
Drospirenone—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000475	0.00913	CcSEcCtD
Drospirenone—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00047	0.00904	CcSEcCtD
Drospirenone—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000458	0.0088	CcSEcCtD
Drospirenone—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000453	0.00872	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000427	0.0082	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000427	0.0082	CcSEcCtD
Drospirenone—BCHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—chronic obstructive pulmonary disease	0.000423	0.0218	CbGpPWpGaD
Drospirenone—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000418	0.00804	CcSEcCtD
Drospirenone—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000414	0.00795	CcSEcCtD
Drospirenone—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000411	0.00791	CcSEcCtD
Drospirenone—PTGS2—C-MYB transcription factor network—ELANE—chronic obstructive pulmonary disease	0.000409	0.0211	CbGpPWpGaD
Drospirenone—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000403	0.00775	CcSEcCtD
Drospirenone—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.00039	0.00749	CcSEcCtD
Drospirenone—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000386	0.00742	CcSEcCtD
Drospirenone—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000379	0.00728	CcSEcCtD
Drospirenone—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000377	0.00724	CcSEcCtD
Drospirenone—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000375	0.00721	CcSEcCtD
Drospirenone—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000364	0.00699	CcSEcCtD
Drospirenone—PTGS2—Overview of nanoparticle effects—HMOX1—chronic obstructive pulmonary disease	0.000348	0.0179	CbGpPWpGaD
Drospirenone—PGR—Cellular roles of Anthrax toxin—IL1B—chronic obstructive pulmonary disease	0.000345	0.0178	CbGpPWpGaD
Drospirenone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—chronic obstructive pulmonary disease	0.000316	0.0163	CbGpPWpGaD
Drospirenone—Depression—Prednisone—chronic obstructive pulmonary disease	0.000304	0.00585	CcSEcCtD
Drospirenone—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000301	0.00578	CcSEcCtD
Drospirenone—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000299	0.00575	CcSEcCtD
Drospirenone—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.00564	CcSEcCtD
Drospirenone—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000294	0.00564	CcSEcCtD
Drospirenone—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000288	0.00553	CcSEcCtD
Drospirenone—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000277	0.00533	CcSEcCtD
Drospirenone—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000275	0.00529	CcSEcCtD
Drospirenone—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000274	0.00526	CcSEcCtD
Drospirenone—PTGS2—Overview of nanoparticle effects—CRP—chronic obstructive pulmonary disease	0.000272	0.014	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000263	0.0135	CbGpPWpGaD
Drospirenone—PGR—Cellular roles of Anthrax toxin—TNF—chronic obstructive pulmonary disease	0.00025	0.0129	CbGpPWpGaD
Drospirenone—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000248	0.00478	CcSEcCtD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000248	0.0128	CbGpPWpGaD
Drospirenone—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.00024	0.00461	CcSEcCtD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—HDAC2—chronic obstructive pulmonary disease	0.000235	0.0121	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—HDAC2—chronic obstructive pulmonary disease	0.000233	0.012	CbGpPWpGaD
Drospirenone—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.000227	0.0117	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.000226	0.0117	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—MMP12—chronic obstructive pulmonary disease	0.000222	0.0114	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—CYP1A2—chronic obstructive pulmonary disease	0.000208	0.0107	CbGpPWpGaD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000202	0.00387	CcSEcCtD
Drospirenone—PTGS2—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000195	0.01	CbGpPWpGaD
Drospirenone—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000191	0.00367	CcSEcCtD
Drospirenone—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000189	0.00363	CcSEcCtD
Drospirenone—BCHE—Peptide hormone metabolism—ACE—chronic obstructive pulmonary disease	0.000188	0.00968	CbGpPWpGaD
Drospirenone—PTGS2—Overview of nanoparticle effects—CXCL8—chronic obstructive pulmonary disease	0.000177	0.00912	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	0.000177	0.0091	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—KL—chronic obstructive pulmonary disease	0.000172	0.00885	CbGpPWpGaD
Drospirenone—BCHE—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000171	0.00878	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000167	0.00861	CbGpPWpGaD
Drospirenone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—chronic obstructive pulmonary disease	0.000165	0.0085	CbGpPWpGaD
Drospirenone—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000159	0.00306	CcSEcCtD
Drospirenone—PTGS2—C-MYB transcription factor network—MPO—chronic obstructive pulmonary disease	0.000158	0.00812	CbGpPWpGaD
Drospirenone—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—chronic obstructive pulmonary disease	0.000152	0.00785	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000152	0.00782	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000151	0.0078	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000151	0.00778	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000151	0.00777	CbGpPWpGaD
Drospirenone—Progesterone—CYP1A1—chronic obstructive pulmonary disease	0.000149	0.189	CrCbGaD
Drospirenone—Progesterone—CYP1A2—chronic obstructive pulmonary disease	0.000144	0.182	CrCbGaD
Drospirenone—PTGS2—S1P1 pathway—VEGFA—chronic obstructive pulmonary disease	0.000144	0.00741	CbGpPWpGaD
Drospirenone—Norethindrone—ALB—chronic obstructive pulmonary disease	0.000143	0.18	CrCbGaD
Drospirenone—PTGS2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000142	0.00729	CbGpPWpGaD
Drospirenone—Testosterone—CYP1A1—chronic obstructive pulmonary disease	0.000141	0.178	CrCbGaD
Drospirenone—BCHE—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000139	0.00716	CbGpPWpGaD
Drospirenone—Methyltestosterone—ALB—chronic obstructive pulmonary disease	0.000136	0.171	CrCbGaD
Drospirenone—NR3C2—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000135	0.00694	CbGpPWpGaD
Drospirenone—BCHE—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000131	0.00673	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—ERBB3—chronic obstructive pulmonary disease	0.000129	0.00664	CbGpPWpGaD
Drospirenone—PTGS2—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.000123	0.00635	CbGpPWpGaD
Drospirenone—BCHE—Peptide hormone metabolism—LEP—chronic obstructive pulmonary disease	0.000117	0.00602	CbGpPWpGaD
Drospirenone—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000116	0.00222	CcSEcCtD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	0.000114	0.00587	CbGpPWpGaD
Drospirenone—BCHE—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000106	0.00548	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000105	0.00538	CbGpPWpGaD
Drospirenone—PTGS2—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	9.95e-05	0.00512	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	9.87e-05	0.00508	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—chronic obstructive pulmonary disease	9.75e-05	0.00502	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	9.25e-05	0.00477	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	9.13e-05	0.0047	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	9.06e-05	0.00467	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	8.91e-05	0.00459	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	8.85e-05	0.00456	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—chronic obstructive pulmonary disease	8.82e-05	0.00454	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	8.21e-05	0.00423	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—chronic obstructive pulmonary disease	8.17e-05	0.00421	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	7.99e-05	0.00412	CbGpPWpGaD
Drospirenone—Testosterone—ALB—chronic obstructive pulmonary disease	7.87e-05	0.0994	CrCbGaD
Drospirenone—BCHE—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	7.7e-05	0.00397	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	7.09e-05	0.00365	CbGpPWpGaD
Drospirenone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	6.67e-05	0.00343	CbGpPWpGaD
Drospirenone—AR—Androgen receptor signaling pathway—EGFR—chronic obstructive pulmonary disease	6.55e-05	0.00337	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—CTGF—chronic obstructive pulmonary disease	6.49e-05	0.00334	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	6.38e-05	0.00329	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	6.26e-05	0.00322	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—LEP—chronic obstructive pulmonary disease	6.18e-05	0.00318	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—APIP—chronic obstructive pulmonary disease	6.16e-05	0.00317	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	6.15e-05	0.00317	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	6.14e-05	0.00316	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.14e-05	0.00316	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	6.12e-05	0.00315	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	6.08e-05	0.00313	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TLR4—chronic obstructive pulmonary disease	6.06e-05	0.00312	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—HDAC2—chronic obstructive pulmonary disease	6.05e-05	0.00311	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—NOS2—chronic obstructive pulmonary disease	5.76e-05	0.00297	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	5.72e-05	0.00294	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—chronic obstructive pulmonary disease	5.69e-05	0.00293	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—EGFR—chronic obstructive pulmonary disease	5.6e-05	0.00288	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	5.48e-05	0.00282	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	5.36e-05	0.00276	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	4.99e-05	0.00257	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	4.77e-05	0.00245	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	4.64e-05	0.00239	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.39e-05	0.00226	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	4.3e-05	0.00222	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.29e-05	0.00221	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—APIP—chronic obstructive pulmonary disease	4.24e-05	0.00218	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	4.11e-05	0.00212	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.08e-05	0.0021	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.06e-05	0.00209	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.05e-05	0.00208	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.98e-05	0.00205	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GC—chronic obstructive pulmonary disease	3.97e-05	0.00204	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—CTGF—chronic obstructive pulmonary disease	3.95e-05	0.00204	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.95e-05	0.00203	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	3.94e-05	0.00203	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	3.74e-05	0.00193	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	3.72e-05	0.00191	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.69e-05	0.0019	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—HDAC2—chronic obstructive pulmonary disease	3.68e-05	0.0019	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	3.62e-05	0.00187	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	3.62e-05	0.00186	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.6e-05	0.00185	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.55e-05	0.00183	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	3.55e-05	0.00183	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	3.38e-05	0.00174	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.28e-05	0.00169	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	3.21e-05	0.00165	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	3.19e-05	0.00164	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	3.06e-05	0.00158	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.02e-05	0.00156	CbGpPWpGaD
Drospirenone—AR—Gene Expression—CTGF—chronic obstructive pulmonary disease	3.01e-05	0.00155	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	3e-05	0.00155	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.98e-05	0.00154	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	2.96e-05	0.00152	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.94e-05	0.00151	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	2.92e-05	0.0015	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	2.86e-05	0.00147	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	2.85e-05	0.00147	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.81e-05	0.00145	CbGpPWpGaD
Drospirenone—AR—Gene Expression—HDAC2—chronic obstructive pulmonary disease	2.81e-05	0.00145	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.79e-05	0.00143	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GC—chronic obstructive pulmonary disease	2.73e-05	0.00141	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.54e-05	0.00131	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	2.52e-05	0.0013	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.4e-05	0.00123	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	2.31e-05	0.00119	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	2.28e-05	0.00117	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.27e-05	0.00117	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.23e-05	0.00115	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	2.21e-05	0.00114	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.17e-05	0.00112	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GCLC—chronic obstructive pulmonary disease	2.14e-05	0.0011	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.08e-05	0.00107	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.05e-05	0.00106	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.04e-05	0.00105	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.02e-05	0.00104	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2e-05	0.00103	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CTGF—chronic obstructive pulmonary disease	1.96e-05	0.00101	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.95e-05	0.001	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.84e-05	0.000946	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.8e-05	0.000928	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.8e-05	0.000928	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.72e-05	0.000884	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.67e-05	0.000859	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.61e-05	0.000827	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.5e-05	0.000774	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	1.5e-05	0.000772	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.49e-05	0.000769	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.49e-05	0.000769	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.48e-05	0.000764	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.48e-05	0.00076	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	1.47e-05	0.000755	CbGpPWpGaD
Drospirenone—PTGS2—Disease—KL—chronic obstructive pulmonary disease	1.39e-05	0.000717	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.38e-05	0.000711	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.38e-05	0.000709	CbGpPWpGaD
Drospirenone—AR—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.37e-05	0.000707	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.35e-05	0.000693	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.31e-05	0.000674	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.24e-05	0.000639	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.17e-05	0.000603	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.12e-05	0.000576	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	1.04e-05	0.000538	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.03e-05	0.000533	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.02e-05	0.000526	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.92e-06	0.000511	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.51e-06	0.00049	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.01e-06	0.000464	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.98e-06	0.000462	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ALB—chronic obstructive pulmonary disease	8.9e-06	0.000458	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	8.71e-06	0.000448	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—NOS3—chronic obstructive pulmonary disease	8.52e-06	0.000439	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.06e-06	0.000415	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.4e-06	0.000381	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	7.33e-06	0.000377	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.25e-06	0.000374	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	7e-06	0.00036	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	6.13e-06	0.000316	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.09e-06	0.000314	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	5.86e-06	0.000302	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.57e-06	0.000287	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	4.63e-06	0.000238	CbGpPWpGaD
Drospirenone—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	4.54e-06	0.000234	CbGpPWpGaD
Drospirenone—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	3.49e-06	0.00018	CbGpPWpGaD
